COSMOS Pharmaceutical Statistics

Total Valuation

COSMOS Pharmaceutical has a market cap or net worth of JPY 575.49 billion. The enterprise value is 562.03 billion.

Market Cap	575.49B
Enterprise Value	562.03B

Important Dates

The last earnings date was Friday, January 10, 2025.

Earnings Date	Jan 10, 2025
Ex-Dividend Date	May 29, 2025

Share Statistics

COSMOS Pharmaceutical has 79.26 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	n/a
Shares Outstanding	79.26M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	38.76%
Owned by Institutions (%)	22.80%
Float	44.18M

Valuation Ratios

The trailing PE ratio is 21.08 and the forward PE ratio is 19.97. COSMOS Pharmaceutical's PEG ratio is 1.83.

PE Ratio	21.08
Forward PE	19.97
PS Ratio	0.58
PB Ratio	2.36
P/TBV Ratio	2.37
P/FCF Ratio	162.80
P/OCF Ratio	n/a
PEG Ratio	1.83

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.84, with an EV/FCF ratio of 158.99.

EV / Earnings	20.59
EV / Sales	0.57
EV / EBITDA	9.84
EV / EBIT	15.61
EV / FCF	158.99

Financial Position

The company has a current ratio of 0.70, with a Debt / Equity ratio of 0.11.

Current Ratio	0.70
Quick Ratio	0.19
Debt / Equity	0.11
Debt / EBITDA	0.45
Debt / FCF	7.26
Interest Coverage	223.65

Financial Efficiency

Return on equity (ROE) is 11.76% and return on invested capital (ROIC) is 8.98%.

Return on Equity (ROE)	11.76%
Return on Assets (ROA)	4.88%
Return on Invested Capital (ROIC)	8.98%
Return on Capital Employed (ROCE)	13.15%
Revenue Per Employee	180.42M
Profits Per Employee	4.95M
Employee Count	5,512
Asset Turnover	2.16
Inventory Turnover	8.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.71% in the last 52 weeks. The beta is 0.18, so COSMOS Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	-7.71%
50-Day Moving Average	7,056.52
200-Day Moving Average	6,956.55
Relative Strength Index (RSI)	52.90
Average Volume (20 Days)	575,785

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, COSMOS Pharmaceutical had revenue of JPY 994.50 billion and earned 27.30 billion in profits. Earnings per share was 344.38.

Revenue	994.50B
Gross Profit	201.45B
Operating Income	36.01B
Pretax Income	37.95B
Net Income	27.30B
EBITDA	57.11B
EBIT	36.01B
Earnings Per Share (EPS)	344.38

Full Income Statement

Balance Sheet

The company has 39.13 billion in cash and 25.68 billion in debt, giving a net cash position of 13.45 billion or 169.75 per share.

Cash & Cash Equivalents	39.13B
Total Debt	25.68B
Net Cash	13.45B
Net Cash Per Share	169.75
Equity (Book Value)	243.49B
Book Value Per Share	3,072.08
Working Capital	-62.81B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 53.31 billion and capital expenditures -49.78 billion, giving a free cash flow of 3.54 billion.

Operating Cash Flow	53.31B
Capital Expenditures	-49.78B
Free Cash Flow	3.54B
FCF Per Share	44.60

Full Cash Flow Statement

Margins

Gross margin is 20.26%, with operating and profit margins of 3.62% and 2.74%.

Gross Margin	20.26%
Operating Margin	3.62%
Pretax Margin	3.82%
Profit Margin	2.74%
EBITDA Margin	5.74%
EBIT Margin	3.62%
FCF Margin	0.36%

Dividends & Yields

This stock pays an annual dividend of 65.00, which amounts to a dividend yield of 0.90%.

Dividend Per Share	65.00
Dividend Yield	0.90%
Dividend Growth (YoY)	8.33%
Years of Dividend Growth	2
Payout Ratio	17.44%
Buyback Yield	-0.06%
Shareholder Yield	0.83%
Earnings Yield	4.74%
FCF Yield	0.61%

Dividend Details

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 2.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	2

Scores

COSMOS Pharmaceutical has an Altman Z-Score of 4.21.

Altman Z-Score	4.21
Piotroski F-Score	n/a